乳腺癌结果的农村和收入:对SEER数据库的分析
Suniah Ayub1, Angelo Marra2, Yuan Liu2
1Department of Surgery and Winship Cancer Institute, Emory Winship Cancer Institute at ESJH, Emory University, Atlanta, GA, USA. sayub@emory.edu.
Annals of surgical oncology
|February 19, 2026
概括
农村低收入地区的乳腺癌患者与城市患者相比,在诊断和治疗方面存在差异. 了解农村和收入之间的复杂相互作用对于解决这些健康不平等至关重要.
科学领域:
- 在瘤学瘤学.
- 健康差距 研究 研究 研究 研究
- 流行病学 流行病学
背景情况:
- 乳腺癌的结果因社会经济地位和地理位置而异.
- 关于农村和收入对乳腺癌患者结果的综合影响的研究有限.
- 需要国家一级的数据来理解这些复杂的相互作用.
研究的目的:
- 研究住宅农村和收入水平对乳腺癌临床表现和治疗模式的相互作用.
- 确定与农村和低收入地位相交的乳腺癌护理差异.
- 为未来的干预提供数据,旨在减少乳腺癌的不平等.
主要方法:
- 利用国家癌症研究所的监测,流行病学和最终结果 (SEER) 计划 (2004-2020年) 进行乳腺癌诊断.
- 用SEER的农村-城市连续代码将患者的位置分类为农村或城市.
- 定义收入为较低 (≤55,000美元) 或较高 (>55,000美元) 和按农村和收入分层的数据.
主要成果:
- 在815,220例中,57,063例是农村低收入 (RLI),55,667例是城市低收入 (ULI),29,762例是农村高收入 (RHI),672,728例是城市高收入 (UHI).
- 与ULI患者相比,RLI患者更有可能被诊断为局部疾病,并且在诊断时年龄较大.
- 与RLI患者相比,ULI患者表现出更高的雌激素受体阴性和HER2阳性疾病率,并且接受了更多的淋巴切除术,化疗和放射治疗.
结论:
- 收入水平和居住环境都与乳腺癌临床表现和治疗的差异独立相关.
- 农村和收入之间的相互作用显著影响乳腺癌的结果,需要进一步研究.
- 了解这些差异的地理空间分布对于开发有针对性的干预措施至关重要.
相关概念视频
Cancer Survival Analysis
788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788
Statistical Methods for Analyzing Epidemiological Data
1.0K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.0K
Comparing the Survival Analysis of Two or More Groups
637
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
637
Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
Bias in Epidemiological Studies
1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.4K
Kaplan-Meier Approach
648
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
648


